In a study of almost 48,900 vaccinated individuals, investigators observed a temporal association between development of Bell’s palsy and administration of quadrivalent meningococcal conjugate vaccine (MCV4) that protects against serogroups A,C, Y, and W (MenACWY) when the vaccine was given at the same time as other vaccines.
The goal of this activity is to educate pharmacists and pharmacy technicians about current vaccine recommendations so that they can identify adolescent and adult patients who may need vaccinations. Readers will also gain knowledge about where to obtain information about current vaccine recommendations.
The American Academy of Pediatrics has announced the release of the 2015 recommended vaccination schedule for children and adolescents in a recent policy statement from the Academy’s Committee on Infectious Diseases.
The first vaccine licensed in the United States to immunize young persons aged 10 through 25 years against invasive meningococcal disease caused by Neisseria meningitidis serogroup B has been approved by the US Food and Drug Administration.
The American Academy of Pediatrics has updated its 2011 policy statement on meningococcal vaccines for children and adolescents to include 2 subsequently licensed conjugate vaccines for use in infants.